filmov
tv
OIS Podcast Ep #402: Venture Insights On Retinal Innovation
Показать описание
Exciting insights from the OIS Retina Panel! Moderated by Dr. Emmett Cunningham, this discussion dives deep into the current state of ophthalmology investment and innovation. Panelists, Anna Chen, Adit Ghosh, Dr. Firas Rahhal and Caroline Stout shared their perspectives on the evolving landscape, highlighting both opportunities and challenges in the field.
Here are the key takeaways:
🔹Cautious Optimism: A resurgence in private markets, but drug development challenges persist.
🔹Growth Areas: Focus on drug delivery, extended-release biologics, and complement inhibitors for dry AMD/GA.
🔹Strategic Partnerships: Crucial for commercialization in ophthalmology.
🔹Emerging Trends: AI’s potential impact and regulatory changes in drug discovery.
🔹Market Concerns: Uncertainties around gene therapy and commercial viability.
Don’t miss out—listen in now to gain valuable insights!
Website:
FOLLOW Ophthalmology Innovation Source On Social Media:
JOIN Our Group For Ophthalmology Innovation & Investment On LinkedIn
SUBSCRIBE To Our Weekly OIS Newsletter
VIEW Our Past Ophthalmology Event Conferences:
REGISTER For Our Next Meeting:
#OIS #Ophthalmology #Healthcare #Ophthalmic #Medicalinnovation #Retina #Eyediseases
_________________________________________________________________
About OIS
Ophthalmology Innovation Summit (OIS) facilitates meaningful interactions and the exchange of information between clinical, capital, and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.
Since 2009, the Ophthalmology Innovation Summit programs are independently produced conferences presented annually by Healthegy, Inc.
Here are the key takeaways:
🔹Cautious Optimism: A resurgence in private markets, but drug development challenges persist.
🔹Growth Areas: Focus on drug delivery, extended-release biologics, and complement inhibitors for dry AMD/GA.
🔹Strategic Partnerships: Crucial for commercialization in ophthalmology.
🔹Emerging Trends: AI’s potential impact and regulatory changes in drug discovery.
🔹Market Concerns: Uncertainties around gene therapy and commercial viability.
Don’t miss out—listen in now to gain valuable insights!
Website:
FOLLOW Ophthalmology Innovation Source On Social Media:
JOIN Our Group For Ophthalmology Innovation & Investment On LinkedIn
SUBSCRIBE To Our Weekly OIS Newsletter
VIEW Our Past Ophthalmology Event Conferences:
REGISTER For Our Next Meeting:
#OIS #Ophthalmology #Healthcare #Ophthalmic #Medicalinnovation #Retina #Eyediseases
_________________________________________________________________
About OIS
Ophthalmology Innovation Summit (OIS) facilitates meaningful interactions and the exchange of information between clinical, capital, and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.
Since 2009, the Ophthalmology Innovation Summit programs are independently produced conferences presented annually by Healthegy, Inc.
Комментарии